OUHSC to University of Oklahoma Health Sciences Center (OUHSC)

The University of Oklahoma Health Sciences Center (OUHSC) began providing care to those living with HIV in October 1996. We quickly realized that many more medical providers in multiple disciplines were needed to battle this disease. In 2007, OUHSC became the Oklahoma Co-Director site for the Texas-Oklahoma AIDS Education and Training Center providing education to all 77 counties in the State of Oklahoma. Through the years we have partnered with Native American tribes across the state as well as state and local government, AIDS Service Organizations, Historically Black Universities, the Department of Corrections and many medical facilities both small and large.

Today, we are a proud partner of the South-Central AIDS Education and Training Center comprising a five-state region. Our office has a staff of four professionals including an Infectious Diseases specialist and a PharmD HIV specialist. The university setting has allowed us to pull expertise from many different disciplines across campus to train providers throughout the state on interdisciplinary care best practices.

Our vision is to create easily accessible and relevant HIV interprofessional education and training for providers within Oklahoma. Every individual deserves excellence in healthcare and every provider deserves cutting-edge education delivered with excellence.

Meet the Team

colemanJill received her Bachelors in Education from The University of Oklahoma. She worked as a special education teacher for 12 years before taking on the role of Instructional Coordinator & Prevention Educator at the University of Oklahoma Health Sciences Center and the SCAETC.

She has been in her current role for 9 years and received her Masters in Prevention Science from The University of Oklahoma in 2016. As instructional coordinator, Jill manages several large-scale educational projects. They involve cultivating community partnerships, group processes management, the administration and coordination of various instructional programs, conducting needs assessments, developing and implementing training events, and evaluating instructional efforts.

Jill is also responsible for curriculum development and instruction of prevention programs within Oklahoma schools and the community at large. Additionally, she creates and conducts distance learning and face-to-face trainings to a variety of community facilitators regarding best practices in the application of the OUHSC prevention curriculum.

drevetsDr. Drevets is a physician scientist with expertise in neuro-infection/neuro-inflammation and in clinical infectious diseases including treatment of patients with HIV/AIDS. His current positions are a Regents’ Professor and Chief of Infectious Diseases, and Vice Chair for Faculty Affairs in the Dept. of Internal Medicine at the Oklahoma University Health Sciences Center (OUHSC). He also holds an appointment as a Staff Physician at the Oklahoma City Veterans Affairs Medical Center (VAMC).

Dr. Drevets received his M.D. from the University of Kansas School of Medicine (Kansas City, KS) where he was elected to the Alpha Omega Alpha honor medical society. He completed his residency in Internal Medicine at Indiana University School of Medicine and Hospitals (Indianapolis, IN) and his sub-specialty training in Infectious Diseases at the University of Colorado HSC (Denver, CO). He is board certified in Internal Medicine and in Infectious Diseases.

In a typical academic year, Dr. Drevets spends approximately 40% of his time in direct patient care and clinical teaching. Inpatient venues include the Adult Tower of OUMI and the Oklahoma City VAMC. Ambulatory care of patients with HIV/AIDS is performed at the Infectious Diseases Institute of OUHSC. He has been the site Medical Director for the components of the AETC program housed at OUHSC for 10 years and is active in educating learners of all type about HIV/AIDS.

Dr. Drevets science background lies in the areas of monocyte biology, host defenses to infection with intracellular bacteria, and pathogenesis of central nervous system infections. He has a long-standing interest in pathogenesis of infections caused by Listeria monocytogenes, a neuroinvasive bacterial pathogen. Work in his laboratory is directed at finding novel means to limit brain inflammation during antibiotic treatment of L. monocytogenes infection in mice. He is the corresponding PI on an NIH-funded project in neurocysticercosis, a helminthic infection of the brain.

Along with collaborators, he is investigating monocyte mRNA transcripts as a novel diagnostic modality in patients with neurocysticercosis. The clinical site for this project is in the Vellore district of Tamil Nadu, India with laboratory components performed by collaborators in South India (Bengaluru and Vellore) as well as at OUHSC. He has also been involved as one of the Principal Investigators on a Hepatitis C elimination project in the Cherokee Nation in northeastern Oklahoma funded by the Gilead Foundation.

lewisDr. Michelle Lewis is a Clinical Associate Professor with the University of Oklahoma College of Medicine. She graduated from the University of Oklahoma with both a Bachelor’s of Science in Pharmacy and a Doctor of Pharmacy degree.

Dr. Lewis completed a Pharmacy Practice Residency at the University of Washington in Seattle, Washington prior to returning to the University of Oklahoma to complete a specialty residency in Infectious Diseases with an emphasis in HIV care.

She worked in many different facets of pharmacy prior to her faculty appointment including retail, hospital, and psychiatric specialty. Dr. Lewis began her teaching career as an instructor at Oregon State University and joined the faculty at the University of Oklahoma College of Pharmacy in 2007.

She spent 12 years with the College of Pharmacy prior to transitioning January 2020 to the College of Medicine in order to focus her efforts more clinically. Dr. Lewis is a Board-Certified Pharmacotherapy Specialist and is credentialed as an HIV Pharmacist by the American Academy of HIV Medicine.

For nine years, she also served as the Program Director for a PGY-2 HIV Pharmacotherapy residency at the University of Oklahoma. She currently serves as a clinical pharmacist in the Infectious Diseases Institute on the University of Oklahoma Health Sciences Center campus and works as part of the AIDS Education and Training Center team at the University of Oklahoma College of Medicine

newportWendy Newport received her Bachelor’s degree in secondary education from the University of Oklahoma (OU). In 1991, she joined the University of Oklahoma’s campus health center in Norman. In an effort to remain in health care and make a public health impact, Ms. Newport obtained a Master of Business and a Master of Public Health from OU and the University of Oklahoma Health Sciences Center (OUHSC).

As the Business Administrator and Ryan White Program Administrator for the University of Oklahoma Health Sciences Center, Ms. Newport has spent the last twenty-one years of her career building the Ryan White program from a small, initial Part C award into a comprehensive, multi-funded, client-focused clinical setting for PLWHs in Oklahoma.

In addition, she is the Oklahoma Program Director for the South Central AIDS Education and Training Center. She has expertise as a national consultant for HRSA/HAB Ryan White related to site visits and technical assistance requests. Her particular areas of interest include interdisciplinary training, fiscal and administrative aspects of programs and assisting others in finding solutions that address both legislative policy and an organization’s needs.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). Under grant number U1OHA33225 (South Central AIDS Education and Training Center). It was awarded to the University of New Mexico. No percentage of this project was financed with non-governmental sources. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.